pd-1-blocking antibodies bound to t cells monitoring | protocol preview
Published 2 years ago • 73 plays • Length 2:01Download video MP4
Download video MP3
Similar videos
-
2:01
targeted antibody blocking by a dcaf | protocol preview
-
2:20
accelerate pd-1/pd-l1 antibody development with a functional blockade bioassay
-
3:29
pd-l1/pd-1 pathway: a security checkpoint
-
1:16
explaining immunotherapy, pd-l1 and pd-1
-
2:12
cancer immunotherapy | the pd-l1 pathway
-
2:07
immune checkpoint inhibitors, the next generation cancer therapy - creative biolabs
-
4:21
easy-to-grasp explanations: immune checkpoint inhibitors, pd-1, pd-l1, ctla-4
-
1:02:49
pd-l1/pd-1 cancer immunotherapy and new targets - gordon freeman, phd
-
18:58
pd-l1 testing by immunohistochemistry
-
12:12
immune checkpoint proteins
-
0:50
pd-1 and pd-l1 receptors: key players in immunotherapy 🎗️🔬
-
4:27
understanding immunotherapy for nsclc with pd-1 and pd-l1 biomarkers
-
1:41
dual anti–ctla-4 and anti–pd-1 blockade in rare tumors (dart) swog s1609
-
13:27
first-in-human clinical trial of the anti-pd-l1 antibody, ibc-ab002, in early ad
-
0:40
cancer cells inhibit t cells using pd-1/pd-l1 pathway
-
2:32
the growing role of anti-pd1 inhibitors in the frontline treatment of hl
-
0:46
immune checkpoint inhibitors: recent progress and potential biomarkers - 3i pd-l1 overexpression
-
0:45
the what, why, and how of anti-pd-1/pd-l1 immunotherapy for cancer
-
1:03
dr. costa on biomarkers beyond pd-l1 for immunotherapy in nsclc
-
![anti-pd-1/pd-l1 antibodies in lung cancer - video abstract [id 55176]](https://i.ytimg.com/vi/9UUNnpNMpGE/mqdefault.jpg)
2:30
anti-pd-1/pd-l1 antibodies in lung cancer - video abstract [id 55176]
-
2:01
hemocompatibility testing in a flow loop model | protocol preview
-
0:50
how can pd-1 inhibition be enhanced in glioblastoma?